VanEck Pharmaceutical ETF (PPH)

68.01
Delayed Data
As of 4:00pm ET
 +0.77 / +1.15%
Today’s Change
66.59
Today|||52-Week Range
84.27
-11.63%
Year-to-Date
PPH Regular Dividend: PPH will begin trading ex-dividend today with a $0.2696 dividend payable to shareholders of record as of 10/04/22.

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS  US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Performance

1 month-4.92% 3 years+7.57%
3 months-12.20% 5 years+4.94%
1 year-5.89% Since inception+8.13%
Data through 10/01/2022

Quote Details

Previous close$67.24
Open day’s range67.22 – 68.29
Net asset value (NAV)67.25 (09/30/2022)
Daily volume10,433
Average volume (3 months)178,850
Data as of 4:00pm ET, 10/03/2022

Peer Comparisonvs. Health ETFs

 PPHCategory
Performance 5-yr return+4.94%+7.33%
Expense Gross exp ratio0.35%1.00%
Risk 5 year sharpe ratio0.420.42
Net assets$533.2M$2.0B
Average market cap$65.5B$46.3B
Average P/E17.022.1
Dividend / Share--0.27%

Competitors

FHLC Fidelity MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...
XLV Health Care Select Sector SPDR® Fund

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
MCK Mckesson Corp5.79%
AZN AstraZeneca5.33%
LLY Eli Lilly and Co5.31%
MRK Merck5.27%
NVS Novartis5.09%
NVO Novo Nordisk5.06%
TAK Takeda Pharmaceutical5.04%
JNJ Johnson & Johnson5.03%
ABBV AbbVie4.98%
ABC Amerisourcebergen Corp4.98%